-
Group
BackGroupView
-
Who we are
BackWho we areView
- Profile
- Key figures
-
Governance
BackGovernanceView
-
Governance
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Our history
-
Who we are
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
What we do
BackWhat we doView
- At a glance
- Large Industries
- Industrial Merchant
- Healthcare
- Electronics
- Engineering & Construction
- Global Markets & Technologies
-
What we do
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Our strategy
BackOur strategyView
-
Our strategy
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Innovation
BackInnovationView
-
Research & Development
BackResearch & DevelopmentView
-
Research & Development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Digital transformation
-
Global markets & Technologies
BackGlobal markets & TechnologiesView
-
Global markets & Technologies
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Air Liquide Venture Capital
-
Innovation
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Research & Development
-
Sustainable development
BackSustainable developmentView
- Safety
-
Ethics
BackEthicsView
-
Ethics
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Human rights
- Climate objectives
- Environmental data
- Vigilance plan
- Extra-financial ratings
-
Stakeholders
BackStakeholdersView
-
Stakeholders
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Sustainable development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Where we operate
- Group publications
-
Group
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Who we are
-
Businesses
BackBusinessesView
-
Industry
BackIndustryView
-
Industry
-
Healthcare
BackHealthcareView
- Presentation
-
Our expertise
-
Our R&D
- Diseases
-
Public health challenges
BackPublic health challengesView
- Aging population
- Rise in chronic diseases
- Urbanization and lifestyle changes
- Reinventing the hospital
-
Public health challenges
-
Healthcare
-
Electronics
-
Engineering & Construction
BackEngineering & ConstructionView
-
Engineering & Construction
-
Science & New energies
BackScience & New energiesView
-
Science & New energies
-
Businesses
-
Industry
-
Magazine
BackMagazineView
- Industry of the future
- Healthcare
- Energy transition
- Customer experience
- Digitization
- Open innovation
- Science
-
Magazine
- Customers
-
Shareholders
BackShareholdersView
- Stock & Share: shareholders' mag
- Become a shareholder
-
Follow the Air Liquide share
BackFollow the Air Liquide shareView
-
Follow the Air Liquide share
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Factsheets
BackFactsheetsView
- Understanding the stock market
- Stock orders
- Shareholding options
- Registering shares
- Loyalty bonus
- Personal online Account
- Capital gains
- Free share attribution
- Dividend
- Taxation
- Passing on shares
-
Factsheets
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Shareholders' Communication Committee
- Annual General Meeting
- Agenda
-
Media library
BackMedia libraryView
-
Media library
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Contact us
-
Shareholders
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Investors
BackInvestorsView
- Agenda
- Documents & Presentations
- Vara consensus
-
Investing in Air Liquide
BackInvesting in Air LiquideView
-
Investing in Air Liquide
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Credit investor
BackCredit investorView
-
Credit investor
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Governance
BackGovernanceView
- Corporate officers remuneration and regulated commitments
- Board committees
- Capital and articles of association, Internal Regulations, disclosure of share buy-back transactions
-
Governance
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
- Regulated information
- Contact us
-
Investors
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Media
-
Careers
BackCareersView
- Job offers
- I choose Air Liquide
-
Careers at Air Liquide
BackCareers at Air LiquideView
-
Careers at Air Liquide
- Find our job offers
- Spontaneous application
-
You at Air Liquide
BackYou at Air LiquideView
-
You at Air Liquide
- Find our job offers
- Spontaneous application
- Students
-
Graduates
BackGraduatesView
-
Graduates
- Find our job offers
- Spontaneous application
Healthcare: Air Liquide acts for the prevention and research on sleep apnea
On the occasion of the ERS's (European Respiratory Society) annual international seminar, which is held in Amsterdam from 27 to 30 September, Air Liquide Healthcare launches a website entirely dedicated to sleep apnea www.all-about-sleep-apnea.com, and presents results of a study comparing medical devices for the treatment of this syndrome, performed with Air Liquide Healthcare’s support.
Sleep apnea syndrome is a sleeping disorder characterized by repetitive brief interruptions in breathing. It is estimated that between 1 and 6% of the global population suffers from it1. It has a direct effect on quality of life and health, and can also lead to serious cardiovascular disorders, like heart attacks and cerebrovascular accidents (CVA).
Although this condition is widespread, around 80% of people concerned are not aware that they suffer from obstructive sleep apnea2. As a key player in the care of patients suffering from this disease, Air Liquide Healthcare is committed to informing the general public and promoting dialogue with patients and healthcare professionals thanks to this new dedicated website www.all-about-sleep-apnea.com. Aimed at users and patients, this site is organized by the main themes that interest them. It contains a variety of sections with written or video testimonials from patients and medical experts. A twitter account has also been created to relay key information (twitter account address: @SleepApneaAbout).
Continuous Positive Airway Pressure (CPAP) is the leading treatment3 for sleep-disordered breathing. Air Liquide Healthcare supported the first bench evaluation aiming to compare the therapeutic efficacy of 11 auto-titrating positive airway pressure (APAP). Carried out by Doctor Sami Aouf and Mr Kaixian Zhu of the medico-technical department of Air Liquide Home Healthcare activity in Europe, in collaboration with the team of Professor Pierre Escourrou of the Antoine-Béclère hospital in Clamart, this study will enable to improve the treatment's therapeutic efficacy as well as compliance. The results of this study were published in the scientific publication “Journal of Clinical Sleep Medicine”4.
1 World Health Organisation. Chronic respiratory diseases
www.who.int/gard/publications/chronic_respiratory_diseases.pdf viewed 04/10/2015
2 Kapur V et al. The Medical cost of undiagnosed sleep apnea. Sleep. 1999; 22(6): 749-55.
3 Clinical Guidelines for the Manual Titration of Positive Airway Pressure in Patients with Obstructive Sleep Apnea, Positive Airway Pressure Titration Task Force of the American Academy of Sleep Medicine, Journal of Clinical Sleep Medicine, Vol. 4, No. 2, 2008
4 All APAPs are not equivalent for the treatment of sleep-disordered breathing: a bench evaluation of 11commercially available devices” (J Clin Sleep Med. 2015 Jan 26. pii: jc-00288-14). Links to the article: [www.ncbi.nlm.nih.gov/pubmed/25766708] and [www.aasmnet.org/jcsm/ViewAbstract.aspx?pid=30091].
© Air Liquide 2019